Journal article · Conference paper
Abstract CT103: Final results for OptimalTTF-1: Optimizing Tumor Treating Fields with targeted skull remodeling surgery for first recurrence glioblastoma: Phase 1 trial
Aarhus University1
Department of Health Technology, Technical University of Denmark2
Magnetic Resonance, Department of Health Technology, Technical University of Denmark3
Neurophysics, Magnetic Resonance, Department of Health Technology, Technical University of Denmark4
Champalimaud Centre for the Unknown5
Aarhus University Hospital6
We present a clinical open label, phase-1 trial (OptimalTTF-1, NCT02893137), which aims to test a novel treatment for first recurrence glioblastoma (rGBM). The aim of the treatment is to optimize the electric field generated by Tumor Treating Fields (TTFields) with targeted and individualized skull-remodeling surgery (SR-surgery).
Selectively placed burrholes reduces the electric resistance created by the bone and thus improves the electric field focally. Preclinical research has indicated this conclusion. The final analysis examined the toxicity and efficacy of this combined intervention in addition to best practice chemotherapy.
Language: | English |
---|---|
Year: | 2020 |
Pages: | CT103-CT103 |
Proceedings: | AACR Annual Meeting 2020 |
ISSN: | 15387445 , 00085472 and 05766656 |
Types: | Journal article and Conference paper |
DOI: | 10.1158/1538-7445.AM2020-CT103 |
ORCIDs: | Thielscher, Axel , 0000-0003-4285-8171 and 0000-0001-5139-7405 |